Kidney transplantation is the best treatment option for end stage renal disease and the impact of cancer affecting the transplanted graft is higher when compared to the general population. It significantly affects the patient quality of life, meaning return to dialysis, along with worse life expectancy. It is therefore envisaged to be able to discern between benign lesion treatable conservatively or with surveillance and those requiring graft nephrectomy. In particular, misdiagnosis of rare entities such as myelolipoma, could represent a challenge requiring dedicate expertise

Myelolipoma in the kidney transplant: a unique entity to be acknowledged / Bellini, M. I.; Magowan, H.; Houghton, O.; Reid, J.; McDaid, J.. - In: ULSTER MEDICAL JOURNAL. - ISSN 0041-6193. - 89:2(2020), pp. 128-129.

Myelolipoma in the kidney transplant: a unique entity to be acknowledged

Bellini M. I.
Primo
;
2020

Abstract

Kidney transplantation is the best treatment option for end stage renal disease and the impact of cancer affecting the transplanted graft is higher when compared to the general population. It significantly affects the patient quality of life, meaning return to dialysis, along with worse life expectancy. It is therefore envisaged to be able to discern between benign lesion treatable conservatively or with surveillance and those requiring graft nephrectomy. In particular, misdiagnosis of rare entities such as myelolipoma, could represent a challenge requiring dedicate expertise
File allegati a questo prodotto
File Dimensione Formato  
Bellini_Myelolipoma-in-the-kidney-transplant_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 673.33 kB
Formato Adobe PDF
673.33 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1601283
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact